Now, there's a generic form of this injectable blood thinner for patients who require anticoagulation therapy. Here's a snippet from a recent FDA press release:
The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used for multiple indications including prevention of deep vein thrombosis (DVT), a potentially deadly blood clotting condition.
Approved for use in 1993, Lovenox is made from heparin, a blood-thinning drug whose active ingredient is a naturally-derived complex mixture of sugar molecules.Every time a generic drug gets approved, I'm reminded that time passes by so quickly. In some ways, it feels like yesterday when the branded drug received FDA approval.